Biomarkers Market Size Worth USD 147.46 Billion by 2034 | CAGR: 9.84%
The biomarkers market size is expected to reach USD 147.46 Billion by 2034, according to a new study by Polaris Market Research. The report “Biomarkers Market Size, Share, Trends, & Industry Analysis By Type, (Safety Biomarkers, Efficacy Biomarkers, and Validation Biomarkers), By Research Area, By Technology, By Disease Indication, By Application, and By Region – Market Forecast, 2026–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The global biomarkers market continues to expand due to its growing use across clinical diagnostics, pharmaceutical research, and health monitoring processes. Biomarkers such as proteins, genes, and metabolites assays serve as biological indicators to measure health status or disease presence. Samples such as blood, tissue, and urine are typically used in laboratory settings to analyze these indicators for medical or research purposes.
Request a free sample copy or read the full market insights: Biomarkers Market report
The adoption of biomarkers is increasing in general health assessments and advanced clinical evaluations across hospitals, diagnostic labs, and research centers. The role of biomarkers in improving clinical workflows and supporting more informed medical decisions continues to grow as laboratory methods become more refined and accessible.
Biomarkers Market Report Highlights
- North America accounted for the largest revenue share of 42.0% in 2025. The leading position is driven by the strong presence of biopharmaceutical and diagnostic companies across the region.
- The U.S. dominated the regional market with 90.0% revenue share in 2025. This is attributed to supportive government initiatives and robust regulatory framework for drug development and deployment.
- The Asia Pacific biomarkers market is expected to register the highest CAGR of 11.50% during the forecast period. Growing healthcare industry and rising prevalence of chronic diseases in the region drive the growth.
- The efficacy biomarkers segment is projected to record a significant CAGR of 10.0% during 2026–2034. This dominance is fueled by the rising use of efficacy biomarkers in evaluating drug responses during clinical trials and monitoring therapeutic outcomes.
- The genomics segment dominated the market with 45.0% revenue share in 2025. The growing use of gene panels, next-generation sequencing, and genome-wide association studies drives the segment growth.
- A few global key market players include Abbott Laboratories, Agilent Technologies, Inc., BioMérieux SA, Bio-Rad Laboratories, Inc., Charles River Laboratories International, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd, Guardant Health, Inc., Illumina, Inc., Merck KGaA, QIAGEN N.V., Revvity, Inc.
Polaris Market Research has segmented the market report on the basis of type, research area, technology, disease indication, application, and region:
By Type Outlook (Revenue, USD Billion, 2021–2034)
- Safety Biomarkers
- Efficacy Biomarkers
- Validation Biomarkers
By Research Area Outlook (Revenue, USD Billion, 2021–2034)
- Genomics
- Proteomics
- Metabolomics
- Other Research Areas
By Technology Outlook (Revenue, USD Billion, 2021–2034)
- Immunoassays
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Mass Spectrometry
- Chromatography
- Other Technologies
By Disease Indication Outlook (Revenue, USD Billion, 2021–2034)
- Cancer
- Infectious Disease
- Immunological Disorders
- Neurological Disorders
- Cardiovascular Disorders
- Other Disease Indications
By Application Outlook (Revenue, USD Billion, 2021–2034)
- Clinical Diagnostics
- Drug Discovery & Development
- Personalized Medicine
- Clinical Research
- Other Application
By Regional Outlook (Revenue, USD Billion, 2021–2034)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
